354 related articles for article (PubMed ID: 25561795)
1. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
2. The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins.
He Y; Yan W; Coito C; Li Y; Gale M; Katze MG
J Gen Virol; 2003 Mar; 84(Pt 3):535-543. PubMed ID: 12604803
[TBL] [Abstract][Full Text] [Related]
3. Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation.
Johansen LK; Morrow CD
J Virol; 2000 Sep; 74(18):8335-42. PubMed ID: 10954532
[TBL] [Abstract][Full Text] [Related]
4. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S
PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705
[TBL] [Abstract][Full Text] [Related]
5. PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.
Rivas-Estilla AM; Svitkin Y; Lopez Lastra M; Hatzoglou M; Sherker A; Koromilas AE
J Virol; 2002 Nov; 76(21):10637-53. PubMed ID: 12368306
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
[TBL] [Abstract][Full Text] [Related]
7. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site in vivo.
Liang XS; Lian JQ; Zhou YX; Wan MB
World J Gastroenterol; 2004 Mar; 10(5):664-7. PubMed ID: 14991934
[TBL] [Abstract][Full Text] [Related]
9. IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3'UTR.
Weinlich S; Hüttelmaier S; Schierhorn A; Behrens SE; Ostareck-Lederer A; Ostareck DH
RNA; 2009 Aug; 15(8):1528-42. PubMed ID: 19541769
[TBL] [Abstract][Full Text] [Related]
10. Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation.
Wang Z; Wu L; Cheng X; Liu S; Li B; Li H; Kang F; Wang J; Xia H; Ping C; Nassal M; Sun D
PLoS One; 2013; 8(4):e60306. PubMed ID: 23589756
[TBL] [Abstract][Full Text] [Related]
11. [Antiviral activities of ISG20 against hepatitis C virus].
Xu H; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):33-7. PubMed ID: 23663760
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA 122 Affects both the Initiation and the Maintenance of Hepatitis C Virus Infections.
Panigrahi M; Thibault PA; Wilson JA
J Virol; 2022 Feb; 96(4):e0190321. PubMed ID: 34908444
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of a poliovirus/hepatitis C virus chimera: new structure for domain II of the internal ribosomal entry site of hepatitis C virus.
Zhao WD; Wimmer E
J Virol; 2001 Apr; 75(8):3719-30. PubMed ID: 11264361
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines.
Koev G; Duncan RF; Lai MM
Virology; 2002 Jun; 297(2):195-202. PubMed ID: 12083818
[TBL] [Abstract][Full Text] [Related]
15. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
[TBL] [Abstract][Full Text] [Related]
16. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T
J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.
Korf M; Jarczak D; Beger C; Manns MP; Krüger M
J Hepatol; 2005 Aug; 43(2):225-34. PubMed ID: 15964661
[TBL] [Abstract][Full Text] [Related]
19. Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.
Yon C; Viswanathan P; Rossignol JF; Korba B
Antiviral Res; 2011 Sep; 91(3):233-40. PubMed ID: 21703309
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
